Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 24729-96-2 | Product Number: C2257
Clindamycin Phosphate
×
![]()
×
Purity: >97.0%(T)
Synonyms:
- Clindamycin 2-Dihydrogen Phosphate
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
£42.00
|
1 | ≥80 |
|
| 25G |
£131.00
|
1 | 25 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | C2257 |
| Purity / Analysis Method | >97.0%(T) |
| Molecular Formula / Molecular Weight | C__1__8H__3__4ClN__2O__8PS = 504.96 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 24729-96-2 |
| Reaxys Registry Number | 463386 |
| PubChem Substance ID | 87560447 |
| Merck Index (14) | 2356 |
| MDL Number | MFCD07793328 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(Nonaqueous Titration) | min. 97.0 %(calcd.on anh.substance) |
| Specific rotation [a]20/D | +115.0 to +130.0 deg(C=1, H2O)(calcd.on anh.substance) |
| Water | max. 6.0 % |
Properties (reference)
| Melting Point | 114 °C |
| Specific Rotation | 122° (C=1,H2O) |
| Solubility in water | Soluble |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| EC Number | 246-433-0 |
| RTECS# | GF2625000 |
Transport Information:
| HS Number | 2941900000 |
Application
Clindamycin Phosphate: A Water Soluble Clindamycin
Clindamycin phosphate is a prodrug of lincosamide antibiotic clindamycin hydrochloride [C2256], and is designed as a highly water soluble form of the poorly water soluble parent compound clindamycin. Meanwhile, clindamycin phosphate has been used as a chiral selector.
References
- Parenteral development of clindamycin-2-phosphate (a review)
- K. W. Riebe, T. O. Oesterling, Bull. Parenteral Drug Assoc. 1972, 26, 139.
- Case Study: Clindamycin 2-Phosphate, A Prodrug of Clindamycin (a review)
- Investigation of enantiomeric separation of basic drugs by capillary electrophoresis using clindamycin phosphate as a novel chiral selector
- Evaluation of the enantioseparation capability of the novel chiral selector clindamycin phosphate towards basic drugs by micellar electrokinetic chromatography
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.